India, Oct. 25 -- Distressed healthtech startup PharmEasy's subsidiary Docon Technologies has offloaded 53.3 Lakh equity shares or about 10% stake in listed subsidiary Thyrocare via a bulk deal on October 24 (Friday).

The company raked in a total of INR 667.7 Cr share via the block deal, which valued each share at INR 1,252.03, a slight discount from Thyrocare's Friday closing price of INR 1,265.40. The shares were lapped up by mutual funds (MF) Aditya Birla Sun Life MF, HDFC, HSBC Midcap fund, ICICI Prudential along with investors Neo Apex Venture and Eastspring Investments India.

Following this transaction, PharmEasy's ownership in Thyrocare will reduce to 60.93% from the 70.98% stake it held previously.

Important to note that PharmE...